PNC Financial Services Group’s Atea Pharmaceuticals AVIR Stock Holding History

PNC Financial Services Group’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.5K	Buy	3,076 +231	+8%	+$1.06K	﹤0.01%	3769
2025 Q4	$10.2K	Sell	2,845 -906	-24%	-$2.88K	﹤0.01%	3940
2025 Q3	$10.9K	Sell	3,751 -543	-13%	-$1.85K	﹤0.01%	3903
2025 Q2	$15.5K	Buy	4,294 +3,402	+381%	+$10.1K	﹤0.01%	3687
2025 Q1	$2.67K	Buy	892 +843	+1,720%	+$2.63K	﹤0.01%	4266
2024 Q4	$164	Sell	49 -1,467	-97%	-$4.88K	﹤0.01%	4666
2024 Q3	$5.08K	Buy	1,516 +1,260	+492%	+$4.57K	﹤0.01%	4034
2024 Q2	$847	Buy	256 +157	+159%	+$585	﹤0.01%	4460
2024 Q1	$400	Buy	99 +25	+34%	+$98	﹤0.01%	4523
2023 Q4	$226	Buy	+74	New	+$224	﹤0.01%	4478
2022 Q4	–	Sell	-5,000	Closed	-$28K	–	4763
2022 Q3	$28K	Hold	5,000	–	–	﹤0.01%	3275
2022 Q2	$36K	Hold	5,000	–	–	﹤0.01%	3176
2022 Q1	$36K	Sell	5,000 -132,050	-96%	-$897K	﹤0.01%	3278
2021 Q4	$1.23M	Buy	137,050 +132,050	+2,641%	+$2.06M	﹤0.01%	1173
2021 Q3	$175K	Hold	5,000	–	–	﹤0.01%	2280
2021 Q2	$107K	Hold	5,000	–	–	﹤0.01%	2614
2021 Q1	$309K	Hold	5,000	–	–	﹤0.01%	1888
2020 Q4	$209K	Buy	+5,000	New	+$161K	﹤0.01%	2044

Other funds holding AVIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PNC Financial Services Group's AVIR Position: Q1 2026 in Review

PNC Financial Services Group increased its Atea Pharmaceuticals (AVIR) stake by 8.1% in Q1 2026, buying an estimated $1.06K and bringing the position to 3,076 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3769.

PNC Financial Services Group first reported a position in AVIR in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.23M in Q4 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

PNC Financial Services Group held 3,076 shares of Atea Pharmaceuticals worth $16.5K as of Q1 2026.
PNC Financial Services Group bought 231 Atea Pharmaceuticals shares in Q1 2026, an estimated $1.06K.
Atea Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3769 holding.
PNC Financial Services Group first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
PNC Financial Services Group's Atea Pharmaceuticals position peaked at $1.23M in Q4 2021.
127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.